data_1hym_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1hym _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.751 . . . . . . . . 6.4299999999999997 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.8 p -171.05 175.2 4.43 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.401 -0.919 . . . . 5.54 109.86 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.458 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -141.93 144.15 33.62 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.347 -0.941 . . . . 4.0700000000000003 109.967 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.1 m -83.11 114.95 56.33 Favored Pre-proline 0 N--CA 1.486 1.365 0 C-N-CA 119.45 -0.9 . . . . 1.6299999999999999 109.887 179.984 -82.041 -171.919 90.147 104.184 2.02 104.211 175.14 -72.845 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 2' ' ' SER . 15.6 Cg_exo -56.97 -170.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.15 1.9 . . . . 2.3199999999999998 110.306 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.39 158.36 0.18 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.353 -1.499 . . . . 1.6799999999999999 109.353 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.986 ' HB2' ' HG2' ' A' ' 27' ' ' GLN . 20.6 tttm -53.84 100.03 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.387 -0.925 . . . . 1.52 109.917 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.8 p -70.12 -24.13 63.14 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.42 -0.912 . . . . 1.71 109.85 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 p -140.43 108.01 5.6 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.432 -0.907 . . . . 2.1499999999999999 109.785 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.764 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 7.8 m-90 -80.71 171.8 11.42 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 119.356 -0.937 . . . . 1.3899999999999999 109.907 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.764 ' HD2' ' HB3' ' A' ' 9' ' ' TRP . 10.6 Cg_endo -66.62 -113.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.302 2.001 . . . . 1.9399999999999999 110.635 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.519 ' H ' ' HB2' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -155.0 67.76 0.68 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.397 -0.921 . . . . 4.7699999999999996 109.824 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.936 HD22 HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -79.95 29.68 0.27 Allowed 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.438 -0.905 . . . . 3.5699999999999998 109.935 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.95 HG11 ' HA ' ' B' ' 62' ' ' VAL . 22.2 t -58.05 133.36 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 119.412 -0.915 . . . . 1.97 109.925 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.416 ' HA2' ' H ' ' B' ' 61' ' ' VAL . . . 80.27 -4.71 66.19 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.393 -1.483 . . . . 1.46 109.393 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.936 HG13 HD22 ' A' ' 12' ' ' LEU . 13.1 t -84.32 43.11 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 119.377 -0.929 . . . . 2.1600000000000001 109.956 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.472 ' HA3' HG22 ' A' ' 19' ' ' VAL . . . 64.15 130.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.421 -1.471 . . . . 2.52 109.421 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.75 -54.57 32.72 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.332 -1.507 . . . . 1.5600000000000001 109.332 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.38 -47.95 47.31 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.398 -0.921 . . . . 2.2400000000000002 109.865 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.596 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 2.2 t -52.52 -58.19 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 119.354 -0.938 . . . . 1.79 109.742 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.67 -39.73 65.35 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.288 -0.965 . . . . 1.4199999999999999 109.597 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 34.0 tttp -60.11 -32.52 71.06 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.41 -0.916 . . . . 1.96 109.685 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.671 ' O ' ' HB2' ' A' ' 26' ' ' ARG . . . -70.56 -42.64 70.87 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.438 -0.905 . . . . 1.5 109.725 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.532 HD13 HD23 ' A' ' 12' ' ' LEU . 5.0 mt -67.6 -42.28 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 119.368 -0.933 . . . . 1.6100000000000001 109.776 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.594 HG22 HG23 ' B' ' 51' ' ' VAL . 79.3 mt -69.21 -45.5 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.389 -0.925 . . . . 1.52 109.817 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 11.0 mm-40 -68.72 -28.85 67.19 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.357 -0.937 . . . . 1.74 109.739 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.671 ' HB2' ' O ' ' A' ' 22' ' ' ALA . 2.1 mtm-85 -77.35 -37.02 53.21 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.428 -0.909 . . . . 4.3399999999999999 109.802 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.986 ' HG2' ' HB2' ' A' ' 6' ' ' LYS . 27.0 tp60 -76.58 -41.13 47.43 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.399 -0.921 . . . . 2.5299999999999998 109.847 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 1.005 ' HB3' HG23 ' A' ' 31' ' ' VAL . 11.5 t-20 -125.38 76.9 68.76 Favored Pre-proline 0 N--CA 1.486 1.359 0 C-N-CA 119.45 -0.9 . . . . 1.21 109.865 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.433 ' HD3' ' C ' ' A' ' 27' ' ' GLN . 13.7 Cg_exo -59.26 1.17 0.37 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.391 2.061 . . . . 1.1699999999999999 110.685 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 28' ' ' ASN . 1.6 m120 -110.64 18.34 19.77 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.342 -0.943 . . . . 2.4500000000000002 110.081 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 1.005 HG23 ' HB3' ' A' ' 28' ' ' ASN . 4.1 m -139.12 143.25 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 119.298 -0.961 . . . . 1.5600000000000001 109.936 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 32' ' ' LYS . 10.7 ttmt -105.71 169.6 8.38 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.475 -0.89 . . . . 4.54 109.893 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.503 ' HB3' HD13 ' B' ' 53' ' ' ILE . . . -129.03 160.06 33.97 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.426 -0.909 . . . . 1.6699999999999999 109.913 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.3 t -131.26 130.91 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 119.415 -0.914 . . . . 2.4700000000000002 109.971 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 mt -88.84 135.22 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.46 -0.896 . . . . 2.02 109.901 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 1.058 HD13 ' HA ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -153.29 151.01 29.53 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.337 -0.945 . . . . 1.76 110.029 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.979 ' HA ' HG21 ' B' ' 55' ' ' VAL . 19.2 mt-10 -80.2 -171.78 3.15 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.512 -0.875 . . . . 2.9500000000000002 109.984 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -94.94 164.25 12.98 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.516 -0.874 . . . . 3.29 109.896 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 176.09 -56.58 0.11 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.356 -1.497 . . . . 2.6899999999999999 109.356 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.734 ' O ' HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -80.14 150.86 72.14 Favored Pre-proline 0 C--N 1.305 -1.327 0 C-N-CA 119.383 -0.927 . . . . 3.3999999999999999 109.841 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -58.21 106.75 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.932 1.755 . . . . 4.5 110.372 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.734 HG21 ' O ' ' A' ' 40' ' ' THR . 0.7 OUTLIER -101.89 161.04 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 119.343 -0.943 . . . . 4.54 109.928 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 44' ' ' LYS . 1.2 t -45.15 105.43 0.06 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.371 -0.932 . . . . 7.4100000000000001 109.83 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 43' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 116.326 -1.797 . . . . 9.6400000000000006 109.908 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 68.3 t0 . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 109.201 -0.666 . . . . 6.96 109.201 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -100.64 89.78 4.03 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.393 -0.923 . . . . 7.1100000000000003 109.878 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ARG . . . . . 0.454 ' HA ' ' HD2' ' B' ' 47' ' ' ARG . 12.3 mmm-85 -100.98 177.35 4.97 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.394 -0.922 . . . . 5.2300000000000004 109.886 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 65.5 m -70.12 3.08 3.0 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.387 -0.925 . . . . 1.1599999999999999 109.879 -179.978 -72.845 175.14 90.147 104.211 2.02 104.184 -171.919 -82.041 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' ASN . . . . . 0.597 ' OD1' ' HG3' ' B' ' 50' ' ' ARG . 52.1 p-10 -112.76 12.43 19.59 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.397 -0.921 . . . . 2.2000000000000002 109.863 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ARG . . . . . 0.597 ' HG3' ' OD1' ' B' ' 49' ' ' ASN . 77.2 mtp85 -139.67 117.91 11.98 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.33 -0.948 . . . . 3.6699999999999999 109.979 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.594 HG23 HG22 ' A' ' 24' ' ' ILE . 2.5 t -107.78 125.55 64.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 119.461 -0.895 . . . . 1.3 109.734 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ARG . . . . . 0.666 ' HG2' HH11 ' B' ' 52' ' ' ARG . 36.8 mtt-85 -96.61 138.17 34.6 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.339 -0.945 . . . . 2.8100000000000001 110.069 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.572 ' O ' HD13 ' A' ' 36' ' ' LEU . 31.0 mt -124.88 122.05 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 119.514 -0.874 . . . . 1.6000000000000001 109.796 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' TRP . . . . . 1.058 ' HA ' HD13 ' A' ' 36' ' ' LEU . 71.0 m95 -94.38 152.52 18.56 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.395 -0.922 . . . . 1.6100000000000001 110.17 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.979 HG21 ' HA ' ' A' ' 37' ' ' GLU . 6.1 m -133.68 123.82 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 119.478 -0.889 . . . . 1.5900000000000001 109.873 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.715 ' OD1' ' HB2' ' B' ' 60' ' ' LEU . 7.8 p30 -89.0 128.25 35.7 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.395 -0.922 . . . . 1.8999999999999999 109.985 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . 0.519 ' C ' ' H ' ' B' ' 59' ' ' GLY . 0.0 OUTLIER -45.07 -22.24 0.09 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.461 -0.896 . . . . 4.2599999999999998 109.852 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' B' ' 56' ' ' ASN . 72.3 mtm180 -52.01 -9.96 0.11 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.412 -0.915 . . . . 5.0599999999999996 109.807 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' B' ' 57' ' ' LYS . . . 96.79 33.31 6.15 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.256 -1.538 . . . . 2.5299999999999998 109.256 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.715 ' HB2' ' OD1' ' B' ' 56' ' ' ASN . 95.2 mt -138.42 159.01 43.16 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.344 -0.942 . . . . 2.2200000000000002 109.997 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . 0.416 ' H ' ' HA2' ' A' ' 14' ' ' GLY . 46.6 t -110.49 101.71 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 119.418 -0.913 . . . . 1.51 109.859 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.95 ' HA ' HG11 ' A' ' 13' ' ' VAL . 1.6 m -80.59 85.34 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 119.407 -0.917 . . . . 1.5600000000000001 110.036 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' SER . . . . . 0.566 ' OG ' HG12 ' B' ' 53' ' ' ILE . 0.3 OUTLIER -90.06 122.97 67.12 Favored Pre-proline 0 N--CA 1.486 1.375 0 C-N-CA 119.479 -0.888 . . . . 1.8300000000000001 109.907 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' B' ' 52' ' ' ARG . 16.4 Cg_exo -56.44 125.47 19.16 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.049 1.833 . . . . 1.6599999999999999 110.372 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' PRO . . . . . 0.496 ' HB3' ' O ' ' A' ' 10' ' ' PRO . 16.3 Cg_exo -56.32 -21.72 37.89 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.046 1.831 . . . . 1.77 110.445 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.05 172.11 7.26 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.374 -0.931 . . . . 4.2000000000000002 109.791 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.498 HG22 HD11 ' B' ' 67' ' ' ILE . 0.9 OUTLIER -81.76 -96.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.314 -0.954 . . . . 2.1800000000000002 109.933 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 CA-C-O 116.342 -2.365 . . . . 3.4100000000000001 109.408 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.751 . . . . . . . . 5.96 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.8 p -171.05 175.2 4.43 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.401 -0.919 . . . . 5.4000000000000004 109.86 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -141.93 144.15 33.62 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.347 -0.941 . . . . 3.7400000000000002 109.967 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.1 m -83.11 114.95 56.33 Favored Pre-proline 0 N--CA 1.486 1.365 0 C-N-CA 119.45 -0.9 . . . . 1.5 109.887 179.984 -82.041 -171.919 90.147 104.184 2.02 104.211 175.14 -72.845 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 2' ' ' SER . 15.6 Cg_exo -56.97 -170.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.15 1.9 . . . . 2.04 110.306 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.39 158.36 0.18 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.353 -1.499 . . . . 1.1699999999999999 109.353 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.993 ' HB2' ' HG2' ' A' ' 27' ' ' GLN . 20.6 tttm -53.84 100.03 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.387 -0.925 . . . . 1.01 109.917 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.8 p -70.12 -24.13 63.14 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.42 -0.912 . . . . 1.48 109.85 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 p -140.43 108.01 5.6 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.432 -0.907 . . . . 1.75 109.785 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.738 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 7.8 m-90 -80.71 171.8 11.42 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 119.356 -0.937 . . . . 1.3899999999999999 109.907 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.738 ' HD2' ' HB3' ' A' ' 9' ' ' TRP . 10.6 Cg_endo -66.62 -113.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.302 2.001 . . . . 1.52 110.635 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.441 ' H ' ' HB2' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -155.0 67.76 0.68 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.397 -0.921 . . . . 4.04 109.824 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.844 ' HG ' HG21 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -79.95 29.68 0.27 Allowed 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.438 -0.905 . . . . 3.0800000000000001 109.935 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.981 HG13 ' HA ' ' B' ' 62' ' ' VAL . 22.2 t -58.05 133.36 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 119.412 -0.915 . . . . 1.5700000000000001 109.925 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.417 ' HA2' ' H ' ' B' ' 61' ' ' VAL . . . 80.27 -4.71 66.19 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.393 -1.483 . . . . 1.3600000000000001 109.393 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.844 HG21 ' HG ' ' A' ' 12' ' ' LEU . 13.1 t -84.32 43.11 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 119.377 -0.929 . . . . 1.6499999999999999 109.956 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 15' ' ' VAL . . . 64.15 130.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.421 -1.471 . . . . 1.77 109.421 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.543 ' HA2' HG11 ' B' ' 61' ' ' VAL . . . -62.75 -54.57 32.72 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.332 -1.507 . . . . 0.98999999999999999 109.332 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.38 -47.95 47.31 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.398 -0.921 . . . . 1.8999999999999999 109.865 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.6 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 2.2 t -52.52 -58.19 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 119.354 -0.938 . . . . 1.1899999999999999 109.742 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.67 -39.73 65.35 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.288 -0.965 . . . . 0.70999999999999996 109.597 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -60.11 -32.52 71.06 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.41 -0.916 . . . . 1.4199999999999999 109.685 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.658 ' O ' ' HB2' ' A' ' 26' ' ' ARG . . . -70.56 -42.64 70.87 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.438 -0.905 . . . . 0.93999999999999995 109.725 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.582 HD12 HD22 ' A' ' 12' ' ' LEU . 5.0 mt -67.6 -42.28 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 119.368 -0.933 . . . . 1.1299999999999999 109.776 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.621 HD13 HG11 ' B' ' 51' ' ' VAL . 79.3 mt -69.21 -45.5 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.389 -0.925 . . . . 0.89000000000000001 109.817 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -68.72 -28.85 67.19 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.357 -0.937 . . . . 1.74 109.739 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.658 ' HB2' ' O ' ' A' ' 22' ' ' ALA . 2.1 mtm-85 -77.35 -37.02 53.21 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.428 -0.909 . . . . 3.7000000000000002 109.802 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.993 ' HG2' ' HB2' ' A' ' 6' ' ' LYS . 27.0 tp60 -76.58 -41.13 47.43 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.399 -0.921 . . . . 2.0499999999999998 109.847 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.785 ' O ' HG22 ' A' ' 31' ' ' VAL . 11.5 t-20 -125.38 76.9 68.76 Favored Pre-proline 0 N--CA 1.486 1.359 0 C-N-CA 119.45 -0.9 . . . . 1.21 109.865 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' C ' ' A' ' 27' ' ' GLN . 13.7 Cg_exo -59.26 1.17 0.37 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.391 2.061 . . . . 1.0700000000000001 110.685 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.498 ' H ' ' C ' ' A' ' 28' ' ' ASN . 21.3 m-20 -110.64 18.34 19.77 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.342 -0.943 . . . . 1.8700000000000001 110.081 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 28' ' ' ASN . 4.1 m -139.12 143.25 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 119.298 -0.961 . . . . 1.04 109.936 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 10.7 ttmt -105.71 169.6 8.38 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.475 -0.89 . . . . 3.9100000000000001 109.893 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.03 160.06 33.97 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.426 -0.909 . . . . 1.1899999999999999 109.913 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.3 t -131.26 130.91 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 119.415 -0.914 . . . . 1.8400000000000001 109.971 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 mt -88.84 135.22 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.46 -0.896 . . . . 1.55 109.901 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.886 HD12 ' HA ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -153.29 151.01 29.53 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.337 -0.945 . . . . 1.24 110.029 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.957 ' HA ' HG22 ' B' ' 55' ' ' VAL . 19.2 mt-10 -80.2 -171.78 3.15 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.512 -0.875 . . . . 2.9500000000000002 109.984 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -94.94 164.25 12.98 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.516 -0.874 . . . . 3.29 109.896 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 176.09 -56.58 0.11 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.356 -1.497 . . . . 2.0899999999999999 109.356 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -80.14 150.86 72.14 Favored Pre-proline 0 C--N 1.305 -1.327 0 C-N-CA 119.383 -0.927 . . . . 3.0299999999999998 109.841 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 40' ' ' THR . 14.7 Cg_exo -58.21 106.75 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.932 1.755 . . . . 4.0499999999999998 110.372 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.89 161.04 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 119.343 -0.943 . . . . 4.54 109.928 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 43' ' ' THR . 1.2 t -45.15 105.43 0.06 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.371 -0.932 . . . . 7.0899999999999999 109.83 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 43' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 116.326 -1.797 . . . . 9.3100000000000005 109.908 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 68.3 t0 . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 109.201 -0.666 . . . . 6.96 109.201 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -100.64 89.78 4.03 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.393 -0.923 . . . . 6.3099999999999996 109.878 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ARG . . . . . 0.509 ' HA ' ' HD2' ' B' ' 47' ' ' ARG . 12.3 mmm-85 -100.98 177.35 4.97 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.394 -0.922 . . . . 4.7300000000000004 109.886 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 65.5 m -70.12 3.08 3.0 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.387 -0.925 . . . . 1.1000000000000001 109.879 -179.978 -72.845 175.14 90.147 104.211 2.02 104.184 -171.919 -82.041 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' ASN . . . . . 0.587 ' OD1' ' HG3' ' B' ' 50' ' ' ARG . 52.1 p-10 -112.76 12.43 19.59 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.397 -0.921 . . . . 1.6699999999999999 109.863 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ARG . . . . . 0.587 ' HG3' ' OD1' ' B' ' 49' ' ' ASN . 77.2 mtp85 -139.67 117.91 11.98 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.33 -0.948 . . . . 3.1099999999999999 109.979 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.621 HG11 HD13 ' A' ' 24' ' ' ILE . 2.5 t -107.78 125.55 64.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 119.461 -0.895 . . . . 0.93000000000000005 109.734 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ARG . . . . . 0.681 ' HG2' HH11 ' B' ' 52' ' ' ARG . 36.8 mtt-85 -96.61 138.17 34.6 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.339 -0.945 . . . . 2.27 110.069 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.601 HG23 ' OG ' ' B' ' 63' ' ' SER . 31.0 mt -124.88 122.05 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 119.514 -0.874 . . . . 1.0900000000000001 109.796 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' TRP . . . . . 0.886 ' HA ' HD12 ' A' ' 36' ' ' LEU . 71.0 m95 -94.38 152.52 18.56 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.395 -0.922 . . . . 1.3799999999999999 110.17 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.957 HG22 ' HA ' ' A' ' 37' ' ' GLU . 6.1 m -133.68 123.82 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 119.478 -0.889 . . . . 1.1200000000000001 109.873 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.709 ' OD1' ' HB2' ' B' ' 60' ' ' LEU . 7.8 p30 -89.0 128.25 35.7 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.395 -0.922 . . . . 1.6399999999999999 109.985 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' B' ' 59' ' ' GLY . 0.0 OUTLIER -45.07 -22.24 0.09 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.461 -0.896 . . . . 3.8900000000000001 109.852 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' B' ' 56' ' ' ASN . 72.3 mtm180 -52.01 -9.96 0.11 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.412 -0.915 . . . . 4.3899999999999997 109.807 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' B' ' 57' ' ' LYS . . . 96.79 33.31 6.15 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.256 -1.538 . . . . 1.8899999999999999 109.256 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.709 ' HB2' ' OD1' ' B' ' 56' ' ' ASN . 95.2 mt -138.42 159.01 43.16 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.344 -0.942 . . . . 1.6399999999999999 109.997 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.543 HG11 ' HA2' ' A' ' 17' ' ' GLY . 46.6 t -110.49 101.71 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 119.418 -0.913 . . . . 0.88 109.859 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.981 ' HA ' HG13 ' A' ' 13' ' ' VAL . 1.6 m -80.59 85.34 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 119.407 -0.917 . . . . 1.0900000000000001 110.036 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' SER . . . . . 0.601 ' OG ' HG23 ' B' ' 53' ' ' ILE . 0.3 OUTLIER -90.06 122.97 67.12 Favored Pre-proline 0 N--CA 1.486 1.375 0 C-N-CA 119.479 -0.888 . . . . 1.4299999999999999 109.907 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 64' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' B' ' 52' ' ' ARG . 16.4 Cg_exo -56.44 125.47 19.16 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.049 1.833 . . . . 1.4399999999999999 110.372 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' PRO . . . . . 0.502 ' HB3' ' O ' ' A' ' 10' ' ' PRO . 16.3 Cg_exo -56.32 -21.72 37.89 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.046 1.831 . . . . 1.5700000000000001 110.445 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.05 172.11 7.26 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.374 -0.931 . . . . 3.5800000000000001 109.791 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.482 ' HB ' ' H ' ' B' ' 68' ' ' GLY . 0.9 OUTLIER -81.76 -96.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.314 -0.954 . . . . 1.75 109.933 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 68' ' ' GLY . . . . . 0.482 ' H ' ' HB ' ' B' ' 67' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.24 0 CA-C-O 116.342 -2.365 . . . . 3.4100000000000001 109.408 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.751 . . . . . . . . 5.96 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.8 p -171.05 175.2 4.43 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.401 -0.919 . . . . 5.4000000000000004 109.86 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -141.93 144.15 33.62 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.347 -0.941 . . . . 3.7400000000000002 109.967 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.1 m -83.11 114.95 56.33 Favored Pre-proline 0 N--CA 1.486 1.365 0 C-N-CA 119.45 -0.9 . . . . 1.5 109.887 179.984 -82.041 -171.919 90.147 104.184 2.02 104.211 175.14 -72.845 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 2' ' ' SER . 15.6 Cg_exo -56.97 -170.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.15 1.9 . . . . 2.04 110.306 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.39 158.36 0.18 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.353 -1.499 . . . . 1.1699999999999999 109.353 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.993 ' HB2' ' HG2' ' A' ' 27' ' ' GLN . 20.6 tttm -53.84 100.03 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.387 -0.925 . . . . 1.01 109.917 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.8 p -70.12 -24.13 63.14 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.42 -0.912 . . . . 1.48 109.85 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 p -140.43 108.01 5.6 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.432 -0.907 . . . . 1.75 109.785 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.738 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 7.8 m-90 -80.71 171.8 11.42 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 119.356 -0.937 . . . . 1.3899999999999999 109.907 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.738 ' HD2' ' HB3' ' A' ' 9' ' ' TRP . 10.6 Cg_endo -66.62 -113.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.302 2.001 . . . . 1.52 110.635 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.441 ' H ' ' HB2' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -155.0 67.76 0.68 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.397 -0.921 . . . . 4.04 109.824 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.844 ' HG ' HG21 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -79.95 29.68 0.27 Allowed 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.438 -0.905 . . . . 3.0800000000000001 109.935 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.981 HG13 ' HA ' ' B' ' 62' ' ' VAL . 22.2 t -58.05 133.36 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 119.412 -0.915 . . . . 1.5700000000000001 109.925 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.417 ' HA2' ' H ' ' B' ' 61' ' ' VAL . . . 80.27 -4.71 66.19 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.393 -1.483 . . . . 1.3600000000000001 109.393 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.844 HG21 ' HG ' ' A' ' 12' ' ' LEU . 13.1 t -84.32 43.11 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 119.377 -0.929 . . . . 1.6499999999999999 109.956 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 15' ' ' VAL . . . 64.15 130.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.421 -1.471 . . . . 1.77 109.421 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.543 ' HA2' HG11 ' B' ' 61' ' ' VAL . . . -62.75 -54.57 32.72 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.332 -1.507 . . . . 0.98999999999999999 109.332 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.38 -47.95 47.31 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.398 -0.921 . . . . 1.8999999999999999 109.865 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.6 ' HB ' ' O ' ' A' ' 15' ' ' VAL . 2.2 t -52.52 -58.19 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 119.354 -0.938 . . . . 1.1899999999999999 109.742 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.67 -39.73 65.35 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.288 -0.965 . . . . 0.70999999999999996 109.597 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -60.11 -32.52 71.06 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.41 -0.916 . . . . 1.4199999999999999 109.685 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.658 ' O ' ' HB2' ' A' ' 26' ' ' ARG . . . -70.56 -42.64 70.87 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.438 -0.905 . . . . 0.93999999999999995 109.725 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.582 HD12 HD22 ' A' ' 12' ' ' LEU . 5.0 mt -67.6 -42.28 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 119.368 -0.933 . . . . 1.1299999999999999 109.776 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.621 HD13 HG11 ' B' ' 51' ' ' VAL . 79.3 mt -69.21 -45.5 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.389 -0.925 . . . . 0.89000000000000001 109.817 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -68.72 -28.85 67.19 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.357 -0.937 . . . . 1.74 109.739 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.658 ' HB2' ' O ' ' A' ' 22' ' ' ALA . 2.1 mtm-85 -77.35 -37.02 53.21 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.428 -0.909 . . . . 3.7000000000000002 109.802 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.993 ' HG2' ' HB2' ' A' ' 6' ' ' LYS . 27.0 tp60 -76.58 -41.13 47.43 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.399 -0.921 . . . . 2.0499999999999998 109.847 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.785 ' O ' HG22 ' A' ' 31' ' ' VAL . 11.5 t-20 -125.38 76.9 68.76 Favored Pre-proline 0 N--CA 1.486 1.359 0 C-N-CA 119.45 -0.9 . . . . 1.21 109.865 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' C ' ' A' ' 27' ' ' GLN . 13.7 Cg_exo -59.26 1.17 0.37 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.391 2.061 . . . . 1.0700000000000001 110.685 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.498 ' H ' ' C ' ' A' ' 28' ' ' ASN . 1.6 m120 -110.64 18.34 19.77 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.342 -0.943 . . . . 1.8700000000000001 110.081 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 28' ' ' ASN . 4.1 m -139.12 143.25 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 119.298 -0.961 . . . . 1.04 109.936 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.482 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 10.7 ttmt -105.71 169.6 8.38 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.475 -0.89 . . . . 3.9100000000000001 109.893 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -129.03 160.06 33.97 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.426 -0.909 . . . . 1.1899999999999999 109.913 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.3 t -131.26 130.91 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 119.415 -0.914 . . . . 1.8400000000000001 109.971 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 mt -88.84 135.22 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.46 -0.896 . . . . 1.55 109.901 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.886 HD12 ' HA ' ' B' ' 54' ' ' TRP . 0.7 OUTLIER -153.29 151.01 29.53 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.337 -0.945 . . . . 1.24 110.029 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.957 ' HA ' HG22 ' B' ' 55' ' ' VAL . 19.2 mt-10 -80.2 -171.78 3.15 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.512 -0.875 . . . . 2.9500000000000002 109.984 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -94.94 164.25 12.98 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 119.516 -0.874 . . . . 3.29 109.896 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 176.09 -56.58 0.11 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.356 -1.497 . . . . 2.0899999999999999 109.356 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -80.14 150.86 72.14 Favored Pre-proline 0 C--N 1.305 -1.327 0 C-N-CA 119.383 -0.927 . . . . 3.0299999999999998 109.841 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 40' ' ' THR . 14.7 Cg_exo -58.21 106.75 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 121.932 1.755 . . . . 4.0499999999999998 110.372 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.89 161.04 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 119.343 -0.943 . . . . 4.54 109.928 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 43' ' ' THR . 1.2 t -45.15 105.43 0.06 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.371 -0.932 . . . . 7.0899999999999999 109.83 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 43' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 116.326 -1.797 . . . . 9.3100000000000005 109.908 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 68.3 t0 . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 109.201 -0.666 . . . . 6.96 109.201 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -100.64 89.78 4.03 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.393 -0.923 . . . . 6.3099999999999996 109.878 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ARG . . . . . 0.509 ' HA ' ' HD2' ' B' ' 47' ' ' ARG . 12.3 mmm-85 -100.98 177.35 4.97 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.394 -0.922 . . . . 4.7300000000000004 109.886 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' CYS . . . . . . . . . . . . . 65.5 m -70.12 3.08 3.0 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.387 -0.925 . . . . 1.1000000000000001 109.879 -179.978 -72.845 175.14 90.147 104.211 2.02 104.184 -171.919 -82.041 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' ASN . . . . . 0.587 ' OD1' ' HG3' ' B' ' 50' ' ' ARG . 52.1 p-10 -112.76 12.43 19.59 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.397 -0.921 . . . . 1.6699999999999999 109.863 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ARG . . . . . 0.587 ' HG3' ' OD1' ' B' ' 49' ' ' ASN . 77.2 mtp85 -139.67 117.91 11.98 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.33 -0.948 . . . . 3.1099999999999999 109.979 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.621 HG11 HD13 ' A' ' 24' ' ' ILE . 2.5 t -107.78 125.55 64.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 119.461 -0.895 . . . . 0.93000000000000005 109.734 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ARG . . . . . 0.681 ' HG2' HH11 ' B' ' 52' ' ' ARG . 36.8 mtt-85 -96.61 138.17 34.6 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.339 -0.945 . . . . 2.27 110.069 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.601 HG23 ' OG ' ' B' ' 63' ' ' SER . 31.0 mt -124.88 122.05 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 119.514 -0.874 . . . . 1.0900000000000001 109.796 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' TRP . . . . . 0.886 ' HA ' HD12 ' A' ' 36' ' ' LEU . 71.0 m95 -94.38 152.52 18.56 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.395 -0.922 . . . . 1.3799999999999999 110.17 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.957 HG22 ' HA ' ' A' ' 37' ' ' GLU . 6.1 m -133.68 123.82 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 119.478 -0.889 . . . . 1.1200000000000001 109.873 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.709 ' OD1' ' HB2' ' B' ' 60' ' ' LEU . 7.8 p30 -89.0 128.25 35.7 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.395 -0.922 . . . . 1.6399999999999999 109.985 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' B' ' 59' ' ' GLY . 0.0 OUTLIER -45.07 -22.24 0.09 Allowed 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.461 -0.896 . . . . 3.8900000000000001 109.852 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' B' ' 56' ' ' ASN . 72.3 mtm180 -52.01 -9.96 0.11 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.412 -0.915 . . . . 4.3899999999999997 109.807 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' B' ' 57' ' ' LYS . . . 96.79 33.31 6.15 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.256 -1.538 . . . . 1.8899999999999999 109.256 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.709 ' HB2' ' OD1' ' B' ' 56' ' ' ASN . 95.2 mt -138.42 159.01 43.16 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.344 -0.942 . . . . 1.6399999999999999 109.997 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.543 HG11 ' HA2' ' A' ' 17' ' ' GLY . 46.6 t -110.49 101.71 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 119.418 -0.913 . . . . 0.88 109.859 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.981 ' HA ' HG13 ' A' ' 13' ' ' VAL . 1.6 m -80.59 85.34 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 119.407 -0.917 . . . . 1.0900000000000001 110.036 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . 0.601 ' OG ' HG23 ' B' ' 53' ' ' ILE . 0.3 OUTLIER -90.06 122.97 67.12 Favored Pre-proline 0 N--CA 1.486 1.375 0 C-N-CA 119.479 -0.888 . . . . 1.4299999999999999 109.907 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' B' ' 52' ' ' ARG . 16.4 Cg_exo -56.44 125.47 19.16 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.049 1.833 . . . . 1.4399999999999999 110.372 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' PRO . . . . . 0.502 ' HB3' ' O ' ' A' ' 10' ' ' PRO . 16.3 Cg_exo -56.32 -21.72 37.89 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.046 1.831 . . . . 1.5700000000000001 110.445 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.05 172.11 7.26 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.374 -0.931 . . . . 3.5800000000000001 109.791 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.482 ' HB ' ' H ' ' B' ' 68' ' ' GLY . 0.9 OUTLIER -81.76 -96.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.314 -0.954 . . . . 1.75 109.933 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . 0.482 ' H ' ' HB ' ' B' ' 67' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.24 0 CA-C-O 116.342 -2.365 . . . . 3.4100000000000001 109.408 179.965 . . . . . . . . 1 1 . 1 stop_ save_